Company page

Eyegene, Inc.

Eyegene, Inc. is a public company listed on the Korean stock market under the ticker 185490. With a market capitalization of approximately 39.26 million, Eyegene focuses on advancements in the biotechnology sector. The company is dedicated to developing innovative solutions in genetic research and healthcare.